Global Regulatory Strategy
Panabistics develops expert-led regulatory strategies for medical device companies entering new markets, developing new products, or evaluating their next regulatory move.
From a structured understanding of your device, intended use, technology, claims, evidence, and target markets, we develop a practical roadmap covering classification, regulatory pathway, evidence expectations, key risks, and recommended actions.
Single-market and multi-market strategy engagements available.
Before Submission
Expensive regulatory mistakes often begin before submission preparation. The wrong classification, pathway, evidence plan, or market sequence can lock a team into work that does not support the intended claims or the selected jurisdictions.
Classification decisions made on incomplete device facts, weak rationale, or the wrong regulatory framework create downstream pathway and evidence errors.
Teams often begin drafting a 510(k), licence, or conformity-assessment package before the applicable market-entry mechanism has been established.
Design, verification, and clinical work started before evidence expectations are understood can miss the studies that later become decisive.
Protocols, acceptance criteria, and sample strategies may be complete and still fail to support the indications, performance, or labeling the company wants to use.
Selecting a first market without considering later jurisdictions can create labeling, evidence, and quality dependencies that are costly to reverse.
Software, cybersecurity, usability, clinical, labeling, or quality requirements identified too late force rework, delays, and weaker submissions.
Different markets approached independently can miss shared evidence needs and the jurisdiction-specific questions that actually change the plan.
Methodology
The underlying product does not change simply because the jurisdiction changes. Panabistics starts with a consistent understanding of the device and then evaluates the regulatory requirements applicable to each selected market. The methodology is jurisdiction-neutral. Each target market applies its own regulatory framework to the same underlying device facts.
Establish a structured profile of the product, intended use, technology, users, claims, evidence, and development status.
Confirm the selected jurisdictions, launch sequence, commercial timing, and whether the engagement is single-market or multi-market.
Apply the relevant regulatory framework to the device profile and identify classification, pathway, evidence, and dependency questions for each market.
Translate the analysis into a practical strategy with rationale, risks, open questions, and recommended next steps.
Device Profile
Panabistics evaluates the product facts that drive regulatory conclusions. Applicable areas vary by device, technology, intended use, and selected markets.
Not every area applies to every device. The intake is scoped to the product, development stage, and regulatory question under review.
Deliverables
The output is a structured, expert-led roadmap that can inform development, testing, labeling, quality, and market-entry decisions.
A concise assessment of the proposed device, assumptions, regulatory objectives, major risks, and recommended direction.
Recommended classification and supporting regulatory rationale for applicable target markets.
Identification of the likely authorization, clearance, licensing, registration, conformity assessment, or other market-entry mechanism applicable to the device.
Where relevant, evaluation of predicates, comparable devices, market precedent, or regulatory comparators.
Identification of expected evidence areas such as performance, bench, clinical, biocompatibility, electrical safety, EMC, software, cybersecurity, usability, sterilization, shelf life, packaging, and other applicable evidence.
Assessment of software, connectivity, cybersecurity, AI/ML, SaMD, mobile, cloud, and other digital-health considerations where applicable.
Identification of important labeling, indications, claims, IFU, warnings, and regulatory positioning issues.
Identification of applicable quality-system, manufacturing, certification, audit, or establishment requirements relevant to the regulatory path.
Identification of key dependencies that could affect the order, timing, or feasibility of market entry.
Identification of unresolved regulatory questions, assumptions requiring confirmation, evidence gaps, and areas where authority interaction may be advisable.
A practical sequence of next steps for progressing toward market authorization.
The exact scope and deliverables are tailored to the device, development stage, target jurisdiction, and regulatory question.
Target Markets
Panabistics develops expert-led strategies for the markets that matter to the engagement. Additional jurisdictions can be evaluated based on client objectives and scope.
FDA regulatory strategy including classification, 510(k), De Novo, PMA, pre-submission considerations, and applicable evidence planning.
Health Canada strategy including device classification, Medical Device Licence considerations, evidence requirements, MDSAP dependencies, and market-entry planning.
EU MDR / IVDR strategy including classification, conformity assessment, technical documentation, clinical and evidence considerations, and Notified Body implications where applicable.
MHRA and Great Britain market-access strategy including classification, registration, conformity assessment, and applicable UK requirements.
Additional jurisdictions can be evaluated based on client objectives and engagement scope. Examples include Australia, Japan, and other international markets when they are part of the commissioned strategy.
Panabistics can develop a coordinated multi-market strategy using the same underlying device profile while identifying jurisdiction-specific requirements and dependencies.
Audience
Before committing significant resources to product development or testing.
When classification, pathway, evidence, or submission strategy needs to be established or challenged.
When an existing device is being evaluated for another regulatory market.
When the regulatory sequence across the U.S., Canada, Europe, Great Britain, or other markets needs to be coordinated.
Including SaMD, AI/ML, connected devices, wearables, diagnostics, combination technologies, and products without an obvious regulatory precedent.
When regulatory feasibility and market-entry risks need to be understood before a transaction or investment decision.
Flexible Engagement Models
Some organizations need a regulatory strategy for one product. Others need a repeatable regulatory framework across multiple devices, jurisdictions, development programs, or business units.
Panabistics can structure Regulatory Strategy engagements around the scale and operating model of the organization.
Engagement Spectrum
A defined regulatory strategy for a specific device, market, development program, or regulatory question.
Suitable forA structured engagement for organizations managing multiple products, markets, or recurring regulatory decisions.
Suitable forFor organizations exploring larger-scale regulatory workflows, pilot programs, tailored operating models, technology partnerships, or future platform capabilities.
Suitable forPanabistics is developing technology to make structured regulatory strategy development increasingly scalable across products and jurisdictions.
Organizations interested in pilot programs, enterprise workflows, licensing opportunities, integrations, or future platform access are invited to speak with us.
How It Works
We establish the product profile, development status, intended use, key claims, available evidence, and commercial objectives.
We evaluate applicable classification, pathways, evidence requirements, standards, dependencies, and regulatory risks for the selected market or markets.
We develop a structured regulatory roadmap with analysis, rationale, assumptions, open questions, and recommended actions.
Panabistics reviews the strategy with the client, discusses major decisions and risks, and defines the next regulatory actions.
Strategic Position
Classification, pathway, evidence, and market-entry decisions should be established before the submission is drafted. A clear regulatory roadmap helps teams decide what to build, what to test, what to claim, and which market to enter first.
This service is an expert-led regulatory strategy engagement. It does not replace regulatory authority review, required testing or validation, legal advice, or the sponsor’s responsibility for the completeness and accuracy of any later submission. Panabistics does not represent FDA, Health Canada, a Notified Body, MHRA, or any other regulatory authority, and does not guarantee authorization, clearance, licensing, or approval.
Request a Strategy
Tell us about the device, intended use, development status, target markets, and whether you need a single strategy, portfolio support, or an enterprise discussion. We will respond within 24 business hours.
Kitchener-Waterloo, Ontario, Canada
Within 24 business hours